Voltaren Arthritis Pain Gel Empowers Early Morning Risers Living with Osteoarthritis
New study reveals the early morning experiences and challenges of those with arthritis joint pain
News provided by
Share this article
Share this article
WARREN, N.J., May 3, 2021 /PRNewswire/ GSK Consumer Healthcare (LSE/NYSE: GSK), the makers of Voltaren Arthritis Pain Gel (diclofenac sodium topical gel, 1%) today revealed new data that uncovers a painful truth: for people with osteoarthritis (OA), mornings can be the most difficult part of the day. The study, conducted by OnePoll on behalf of Voltaren, found that among 1,000 people with OA surveyed, 67% of Americans reported their joint pain makes it difficult for them to get out of bed in the morning based on their activities from the previous day. This May, national Arthritis Awareness Month, Voltaren is empowering those with joint pain and stiffness to feel the joy of movement and help them take on their day.
ET Industry Leaders– MSME West 2020 - Honouring Excellence
SECTIONS
Last Updated: Jan 25, 2021, 03:36 PM IST
Share
Comment
ET Industry Leaders– MSME West 2020 recognized and celebrated visionary businesses, enterprises and individuals who have continued to prove their mettle, exude confidence through innovation and retained their market position over the years and despite the pandemic. Complying with the new normal, the maiden virtual edition of the ET Industry Leaders MSME – West 2020 was aired on ET NOW in December 2020. Prahlad Kakar & Vinod Kumar from India SME Forum, India’s only non-profit, non-political, non-governmental & non-trade association, initiative for Small and Medium Entrepreneurs did the honours of announcing the winners and support the initiative. The recognitions were aimed at boosting the morale and providing motivation to the several businesses that have reached new heights, despite the global economic slowdown.